Recently, MSTO1 was described as a cytosolic mitochondrial fusion protein, and pathogenic variants in MSTO1 have been reported to cause ataxia, muscle weakness, cerebellar atrophy and pigmentary retinopathy [16, 31, 36]. Here, MSTO1 is linked to Pigmentary retinopathy.